| 4 | Statement of changes in beneficial owner... | Apelian David | Broadridge Financial Solutions, Inc. /fa | 07/06/2023 | |
| 4 | Statement of changes in beneficial owner... | Eiger Biopharmaceuticals, Inc. | Broadridge Financial Solutions, Inc. /fa | 07/06/2023 | |
| 4 | Statement of changes in beneficial owner... | Eiger Biopharmaceuticals, Inc. | Broadridge Financial Solutions, Inc./fa | 02/02/2023 | |
| 4 | Statement of changes in beneficial owner... | Eiger Biopharmaceuticals, Inc. | Broadridge Financial Solutions, Inc./fa | 08/18/2022 | |
| 4 | Statement of changes in beneficial owner... | Eiger Biopharmaceuticals, Inc. | Broadridge Financial Solutions, Inc. /fa | 03/11/2022 | |
| 4 | Statement of changes in beneficial owner... | Eiger Biopharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 03/15/2021 | |
| 4 | Statement of changes in beneficial owner... | Eiger Biopharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 03/13/2020 | |
| 4 | Statement of changes in beneficial owner... | Eiger Biopharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 03/26/2019 | |
| 4 | Statement of changes in beneficial owner... | Eiger Biopharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 03/16/2018 | |
| 4 | Statement of changes in beneficial owner... | Eiger Biopharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 01/09/2018 | |
| Load More |
SEC Filing Data
